Current therapeutic strategies for childhood hepatic malignant tumors.

作者: Eiso Hiyama

DOI: 10.1007/S10147-013-0607-9

关键词: MedicineClinical researchOncologySurgical oncologyDifferential diagnosisInternal medicineClinical trialHepatocellular carcinomaHepatoblastomaLiver tumorLiver transplantationGeneral surgery

摘要: The two main malignant hepatic tumors in children are hepatoblastomas (HBLs) and hepatocellular carcinomas (HCCs). past decades have brought significant improvement to the outcomes of diagnosed with tumors, especially HBL, due improvements diagnosis treatment. Histological is essential for differential these tumors. In surgery, liver resection has become a safe secure technique because progress anatomical knowledge surgical dissection; also transplantation widely used unresectable Moreover, introduction effective chemotherapeutic regimens significantly improved survival HBL an increase number patients ultimately undergoing tumor resection, reduction incidence post-surgical recurrence. These result multicenter cooperative trials conducted by Japanese Study Group Pediatric Liver Tumor, Children’s Oncology Group, International Childhood Tumor Strategy including work German Association Hematology Oncology. This paper summarizes results studies calls on current international collaboration study called Hepatic Tumors Collaboration Project establish global clinical research childhood

参考文章(23)
Jörg Fuchs, Jana Rydzynski, Dietrich Von Schweinitz, Udo Bode, Hartmut Hecker, Peter Weinel, Dietrich Bürger, Dieter Harms, Rudolf Erttmann, Karl Oldhafer, Hermann Mildenberger, , Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer. ,vol. 95, pp. 172- 182 ,(2002) , 10.1002/CNCR.10632
Jorge A. Ortega, Edwin C. Douglass, James H. Feusner, Marleta Reynolds, John J. Quinn, Milton J. Finegold, Joel E. Haas, Denis R. King, Wen Liu-Mares, Martha G. Sensel, Mark D. Krailo, Randomized Comparison of Cisplatin/Vincristine/Fluorouracil and Cisplatin/Continuous Infusion Doxorubicin for Treatment of Pediatric Hepatoblastoma: A Report From the Children’s Cancer Group and the Pediatric Oncology Group Journal of Clinical Oncology. ,vol. 18, pp. 2665- 2675 ,(2000) , 10.1200/JCO.2000.18.14.2665
Jon Pritchard, Julia Brown, Elizabeth Shafford, Giorgio Perilongo, Penelope Brock, Claire Dicks-Mireaux, Jean Keeling, Angela Phillips, Anton Vos, Jack Plaschkes, Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma : A successful approach: Results of the first prospective study of the International Society of Pediatric Oncology Journal of Clinical Oncology. ,vol. 18, pp. 3819- 3828 ,(2000) , 10.1200/JCO.2000.18.22.3819
G. Perilongo, E. Shafford, R. Maibach, D. Aronson, L. Brugières, P. Brock, M. Childs, P. Czauderna, G. MacKinlay, J.B. Otte, J. Pritchard, R. Rondelli, M. Scopinaro, C. Staalman, J. Plaschkes, Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2. European Journal of Cancer. ,vol. 40, pp. 411- 421 ,(2004) , 10.1016/J.EJCA.2003.06.003
József Zsiros, Laurence Brugieres, Penelope Brock, Derek Roebuck, Rudolf Maibach, Arthur Zimmermann, Margaret Childs, Daniele Pariente, Veronique Laithier, Jean-Bernard Otte, Sophie Branchereau, Daniel Aronson, Arun Rangaswami, Milind Ronghe, Michela Casanova, Michael Sullivan, Bruce Morland, Piotr Czauderna, Giorgio Perilongo, Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study Lancet Oncology. ,vol. 14, pp. 834- 842 ,(2013) , 10.1016/S1470-2045(13)70272-9
Dolores López-Terrada, Rita Alaggio, Maria T de Dávila, Piotr Czauderna, Eiso Hiyama, Howard Katzenstein, Ivo Leuschner, Marcio Malogolowkin, Rebecka Meyers, Sarangarajan Ranganathan, Yukichi Tanaka, Gail Tomlinson, Monique Fabrè, Arthur Zimmermann, Milton J Finegold, Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium Modern Pathology. ,vol. 27, pp. 472- 491 ,(2014) , 10.1038/MODPATHOL.2013.80
Dolores López-Terrada, Arthur Zimmermann, Current issues and controversies in the classification of pediatric hepatocellular tumors. Pediatric Blood & Cancer. ,vol. 59, pp. 780- 784 ,(2012) , 10.1002/PBC.24214
Giorgio Perilongo, Rudolf Maibach, Elisabeth Shafford, Laurence Brugieres, Penelope Brock, Bruce Morland, Beatriz de Camargo, Jozsef Zsiros, Derek Roebuck, Arthur Zimmermann, Daniel Aronson, Margaret Childs, Eva Widing, Veronique Laithier, Jack Plaschkes, Jon Pritchard, Marcello Scopinaro, Gordon MacKinlay, Piotr Czauderna, Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma The New England Journal of Medicine. ,vol. 361, pp. 1662- 1670 ,(2009) , 10.1056/NEJMOA0810613
Anil Darbari, Keith M Sabin, Craig N Shapiro, Kathleen B Schwarz, Epidemiology of primary hepatic malignancies in U.S. children Hepatology. ,vol. 38, pp. 560- 566 ,(2003) , 10.1053/JHEP.2003.50375